Skip to main content
NVDA+0.10%AAPL-0.38%GOOGL+0.64%MSFT+0.09%AMZN+0.20%TSM+1.02%SPCX-1.36%AVGO+2.97%META+0.35%TSLA-0.11%SKHY+2.46%MU+0.19%BRK-B+0.11%LLY+0.04%JPM+0.10%AMD+2.70%WMT-0.06%V-0.44%XOM+0.17%JNJ-0.09%ASMLa+1.97%INTC-0.18%MA-0.09%0700.HK+2.84%ABBV-0.02%1398.HK+0.90%CSCO-0.66%ORCL-1.98%CVX-0.97%BAC-0.77%COST+0.15%KO+0.22%DELL-3.46%CAT+1.30%LRCX+6.98%0005.HK-0.72%AMAT+6.51%PG-0.79%HSBA.L-1.61%AP2d+5.05%UNH+0.45%3988.HK+0.88%GE+0.26%1816.HK-30.13%MS-0.46%HD-0.84%0939.HK+1.17%NFLX-4.67%0857.HK-0.42%ARM+4.04%GBPTRY+0.41%GBPHKD+0.32%AUDCAD+0.29%GBPMXN-0.28%GBPZAR-0.26%EURZAR-0.25%AUDNOK+0.24%AUDCHF+0.24%USDCAD+0.22%AUDJPY+0.19%CHFSGD-0.18%USDNOK+0.18%GBPAUD-0.16%USDILS+0.16%NZDCAD+0.16%USDZAR-0.15%AUDDKK+0.15%USDCHF+0.15%EURAUD-0.15%SGDJPY+0.14%GBPCAD+0.14%AUDNZD+0.14%NZDMXN-0.13%GBPSGD-0.12%USDJPY+0.12%EURSGD-0.12%NZDCHF+0.11%PLNJPY+0.11%CADJPY-0.11%EURCAD+0.10%NZDSGD-0.10%USDSEK+0.09%GBPUSD-0.09%EURUSD-0.09%EURNOK+0.09%EURCNH-0.09%USDDKK+0.09%EURCHF+0.08%NZDJPY+0.08%AUDUSD+0.08%EURHKD-0.08%USDTRY+0.08%EURPLN-0.07%NZDUSD-0.07%CHFSEK-0.07%CADCHF-0.07%GBPCHF+0.07%USDTHB-0.06%USDMXN-0.06%EURNZD-0.06%NOKJPY-0.05%USDCOP-0.04%USDCNH-0.04%AUDSGD+0.04%GBPJPY+0.03%CHFNOK+0.03%EURJPY+0.03%GBPNZD-0.03%USDSGD-0.03%EURCZK+0.02%USDPLN+0.02%EURGBP+0.02%EURSEK+0.01%USDHKD+0.01%CHFJPY-0.01%EURDKK0.00%COTTON+2.26%USOIL-1.39%W1+1.38%C1+1.23%UKOIL-1.11%XAUUSD-0.66%GAUUSD-0.66%S1+0.58%GAGUSD-0.52%XAGUSD-0.52%XNGUSD-0.38%HG1+0.28%BTCUSD+0.44%ETHUSD+1.12%USDTUSD-0.01%XRPUSD+1.62%SOLUSD+0.87%TRXUSDT+0.99%ZECUSDT+2.33%DOGEUSD+1.43%XMRUSDT+13.87%LINKUSD+0.95%XLMUSD+1.50%UNIUSD-0.45%BCHUSDT+0.15%LTCUSD+0.20%HBARUSDT+6.48%SUIUSD+11.80%TONUSD+24.06%TAOUSDT+2.16%AAVEUSD-1.49%DOTUSDT+2.36%ICPUSDT+1.99%ONDOUSDT+2.86%ARBUSDT+3.89%WLDUSDT+6.29%JUPUSDT+6.96%ATOMUSDT+1.00%INJUSDT-2.30%STXUSDT+1.71%FETUSDT+4.30%TIAUSDT+1.50%SEIUSDT+14.23%PYTHUSDT+0.04%IMXUSDT-0.98%OPUSDT+4.06%GRTUSDT+8.54%WIFUSDT-4.16%IOTAUSDT-1.33%POLUSDT+3.01%AXSUSDT-0.61%FARTCOINUSDT+5.57%EOSUSDT+3.27%DYDXUSDT-0.75%ORDIUSDT+5.68%GALAUSDT+1.80%NOTUSDT+5.67%RONINUSDT-1.03%NVDA+0.10%AAPL-0.38%GOOGL+0.64%MSFT+0.09%AMZN+0.20%TSM+1.02%SPCX-1.36%AVGO+2.97%META+0.35%TSLA-0.11%SKHY+2.46%MU+0.19%BRK-B+0.11%LLY+0.04%JPM+0.10%AMD+2.70%WMT-0.06%V-0.44%XOM+0.17%JNJ-0.09%ASMLa+1.97%INTC-0.18%MA-0.09%0700.HK+2.84%ABBV-0.02%1398.HK+0.90%CSCO-0.66%ORCL-1.98%CVX-0.97%BAC-0.77%COST+0.15%KO+0.22%DELL-3.46%CAT+1.30%LRCX+6.98%0005.HK-0.72%AMAT+6.51%PG-0.79%HSBA.L-1.61%AP2d+5.05%UNH+0.45%3988.HK+0.88%GE+0.26%1816.HK-30.13%MS-0.46%HD-0.84%0939.HK+1.17%NFLX-4.67%0857.HK-0.42%ARM+4.04%GBPTRY+0.41%GBPHKD+0.32%AUDCAD+0.29%GBPMXN-0.28%GBPZAR-0.26%EURZAR-0.25%AUDNOK+0.24%AUDCHF+0.24%USDCAD+0.22%AUDJPY+0.19%CHFSGD-0.18%USDNOK+0.18%GBPAUD-0.16%USDILS+0.16%NZDCAD+0.16%USDZAR-0.15%AUDDKK+0.15%USDCHF+0.15%EURAUD-0.15%SGDJPY+0.14%GBPCAD+0.14%AUDNZD+0.14%NZDMXN-0.13%GBPSGD-0.12%USDJPY+0.12%EURSGD-0.12%NZDCHF+0.11%PLNJPY+0.11%CADJPY-0.11%EURCAD+0.10%NZDSGD-0.10%USDSEK+0.09%GBPUSD-0.09%EURUSD-0.09%EURNOK+0.09%EURCNH-0.09%USDDKK+0.09%EURCHF+0.08%NZDJPY+0.08%AUDUSD+0.08%EURHKD-0.08%USDTRY+0.08%EURPLN-0.07%NZDUSD-0.07%CHFSEK-0.07%CADCHF-0.07%GBPCHF+0.07%USDTHB-0.06%USDMXN-0.06%EURNZD-0.06%NOKJPY-0.05%USDCOP-0.04%USDCNH-0.04%AUDSGD+0.04%GBPJPY+0.03%CHFNOK+0.03%EURJPY+0.03%GBPNZD-0.03%USDSGD-0.03%EURCZK+0.02%USDPLN+0.02%EURGBP+0.02%EURSEK+0.01%USDHKD+0.01%CHFJPY-0.01%EURDKK0.00%COTTON+2.26%USOIL-1.39%W1+1.38%C1+1.23%UKOIL-1.11%XAUUSD-0.66%GAUUSD-0.66%S1+0.58%GAGUSD-0.52%XAGUSD-0.52%XNGUSD-0.38%HG1+0.28%BTCUSD+0.44%ETHUSD+1.12%USDTUSD-0.01%XRPUSD+1.62%SOLUSD+0.87%TRXUSDT+0.99%ZECUSDT+2.33%DOGEUSD+1.43%XMRUSDT+13.87%LINKUSD+0.95%XLMUSD+1.50%UNIUSD-0.45%BCHUSDT+0.15%LTCUSD+0.20%HBARUSDT+6.48%SUIUSD+11.80%TONUSD+24.06%TAOUSDT+2.16%AAVEUSD-1.49%DOTUSDT+2.36%ICPUSDT+1.99%ONDOUSDT+2.86%ARBUSDT+3.89%WLDUSDT+6.29%JUPUSDT+6.96%ATOMUSDT+1.00%INJUSDT-2.30%STXUSDT+1.71%FETUSDT+4.30%TIAUSDT+1.50%SEIUSDT+14.23%PYTHUSDT+0.04%IMXUSDT-0.98%OPUSDT+4.06%GRTUSDT+8.54%WIFUSDT-4.16%IOTAUSDT-1.33%POLUSDT+3.01%AXSUSDT-0.61%FARTCOINUSDT+5.57%EOSUSDT+3.27%DYDXUSDT-0.75%ORDIUSDT+5.68%GALAUSDT+1.80%NOTUSDT+5.67%RONINUSDT-1.03%
GE

GeneDx Holdings Corp. (WGS)

NASDAQ • Healthcare

$101.1
-$3.85 (-3.7%)
Market closed

Last close at September 18, 2026 at 20:00 UTC

Open$104.59
Day Range$99.7 - $105
Avg. Volume (3M)540.1K
Market Cap$3B
52 Week Range
$32.21$170.87
Next EarningsIn 36 daysOct 27, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$114.4M100%
Gross Profitminus cost of goods$78.2M68%

In plain terms: out of every $100 in revenue, GeneDx Holdings Corp. currently loses $16.

Fundamentals & Financials

Revenue (TTM)
$454.4M
Net Income (TTM)
-$106.3M
EPS (TTM)
-$3.64
ROA (TTM)
-22.09%
Current Ratio
3.3

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+27.3%Q1 2026$0.14
-366.7%Q2 2026-$0.28
+105.3%Q3 2026$0.01
Next

Oct 27

in 36 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +105.3%

GeneDx’s second fiscal quarter of 2026 featured revenue that topped consensus, as results reported August 3, 2026 showed revenue of $114.4 million against a $111.0 million estimate (+3.1%), rising 11.4% year over year from $102.7 million. Gross profit came in at roughly $78.2 million, translating to a gross margin of about 68%, while operating results remained negative with operating income of -$17.5 million and an operating margin of around -15%. The quarter ended with net income of -$17.7 million, down from $10.8 million a year ago, and cash generation was also negative, with operating cash flow of -$29.0 million. For the next period, consensus calls for EPS of $0.07 on revenue of $123.0 million.

View full earnings history

About GeneDx Holdings Corp.

GeneDx Holdings Corp. provides genomic testing and data-driven research tools in healthcare and trades on the NASDAQ under WGS. The company uses large clinical and genomic datasets to support diagnostic and research work, and it generated $427.5 million of revenue in FY2025.

Name
GeneDx Holdings Corp.
CEO
Katherine A. Stueland
Website
www.genedx.com
Industry
Healthcare
Year Founded
2015
Employees
1,300

Today's Snapshot

AI-generated

The day ended with WGS 3.7% lower at 101.10, while its sector was flat.

Trading Volume

Above 10d avg 587.5K

675.5K

vs S&P 500 Today

Strong Underperformance

-3.75%

Updated: September 18, 2026 at 20:17 UTC

Technical Indicators

6 Buy0 Neutral2 Sell
WGS is trading around 101.1 and shows a strong, momentum-driven advance with price sitting well above short and medium moving averages and most trend measures flagged bullish. The MACD and momentum readings are strongly positive and ADX above 35 confirms a robust trend, while OBV supports the move with accumulation. Short-term indicators are overbought and the stock is at or slightly above the upper Bollinger band, and volatility is elevated with an ATR near 5.16. The pivot lies above the market and offers a nearby reference. Technical takeaway: strong, momentum-led uptrend with overbought near-term conditions; overall strong buy.
All signals
  • EMA (5 indicators)$76.51 - $93.91
    Buy
  • RSI (14)70.42
    Sell
  • Stochastic %K (14, 3, 3)89.66
    Sell
  • MACD Level (12, 26)5.73
    Buy

Peers & Related Assets

KYMRKymera Therapeutics, Inc.
$117.75-0.6%
CRNXCrinetics Pharmaceuticals, Inc.
$84.950.0%
OSCROscar Health, Inc.
$32.13+0.5%
IMVTImmunovant, Inc.
$36.95-1.9%
OPCHOption Care Health, Inc.
$24.3-0.8%
VKTXViking Therapeutics, Inc.
$28.99-1.3%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.